相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U. S. Preventive Services Task Force Recommendation
Linda L. Humphrey et al.
ANNALS OF INTERNAL MEDICINE (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Endobronchial miRNAs as Biomarkers in Lung Cancer Chemoprevention
Celine Mascaux et al.
CANCER PREVENTION RESEARCH (2013)
Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals
Marjolein A. Heuvelmans et al.
EUROPEAN RADIOLOGY (2013)
Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer: ECOG 5597
Daniel D. Karp et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Glycoproteomic Analysis of Bronchoalveolar Lavage (BAL) Fluid Identifies Tumor-Associated Glycoproteins from Lung Adenocarcinonna
Qing Kay Li et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Screening Outcomes in Older US Women Undergoing Multiple Mammograms in Community Practice: Does Interval, Age, or Comorbidity Score Affect Tumor Characteristics or False Positive Rates?
Dejana Braithwaite et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
Daniel Ajona et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Lung cancer chemoprevention: current status and future prospects
Robert L. Keith et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Stephanie A. Kovalchik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions
Andrea C. Villanti et al.
PLOS ONE (2013)
A Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules
Xiao-jun Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier
Barbara Iyen-Omofoman et al.
THORAX (2013)
Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials
Alissa Greenberg et al.
Cancers (2013)
Added Value of a Serum Proteomic Signature in the Diagnostic Evaluation of Lung Nodules
Chad V. Pecot et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
The State of Molecular Biomarkers for the Early Detection of Lung Cancer
Mohamed Hassanein et al.
CANCER PREVENTION RESEARCH (2012)
Meta-Analysis on the Association Between Nonsteroidal Anti-Inflammatory Drug Use and Lung Cancer Risk
Jiali Xu et al.
CLINICAL LUNG CANCER (2012)
Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
I. N. Colmers et al.
DIABETES & METABOLISM (2012)
Benefits and Harms of CT Screening for Lung Cancer A Systematic Review
Peter B. Bach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability
Kelsie L. Thu et al.
PLOS ONE (2012)
CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
Zaigham Saghir et al.
THORAX (2012)
Screening for Lung Cancer: It Works, but Does It Really Work?
Gerard A. Silvestri
ANNALS OF INTERNAL MEDICINE (2011)
Randomized Phase II Trial of Inhaled Budesonide versus Placebo in High-Risk Individuals with CT Screen-Detected Lung Nodules
Giulia Veronesi et al.
CANCER PREVENTION RESEARCH (2011)
Oral Iloprost Improves Endobronchial Dysplasia in Former Smokers
Robert L. Keith et al.
CANCER PREVENTION RESEARCH (2011)
Lung Cancer Risk Prediction to Select Smokers for Screening CT-a Model Based on the Italian COSMOS Trial
Patrick Maisonneuve et al.
CANCER PREVENTION RESEARCH (2011)
Pentraxin-3 Is a Novel Biomarker of Lung Carcinoma
Eleftherios P. Diamandis et al.
CLINICAL CANCER RESEARCH (2011)
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer
Fabrizio Bianchi et al.
EMBO MOLECULAR MEDICINE (2011)
Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial
K. A. M. van den Bergh et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Screening by Chest Radiograph and Lung Cancer Mortality The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial
Martin M. Oken et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
Denise R. Aberle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer
Rachel M. Ostroff et al.
PLoS One (2011)
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
Edward S. Kim et al.
CANCER PREVENTION RESEARCH (2010)
Effects of Cigarette Smoke on the Human Oral Mucosal Transcriptome
Jay O. Boyle et al.
CANCER PREVENTION RESEARCH (2010)
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Lei Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Dietary Selenium Repletion May Reduce Cancer Incidence in People at High Risk Who Live in Areas with Low Soil Selenium
James C. Fleet
NUTRITION REVIEWS (2010)
Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium
Xiaoling Zhang et al.
PHYSIOLOGICAL GENOMICS (2010)
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development
Adam M. Gustafson et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Associaton of Nonsteroidal Anti-Inflammatory Drugs with Lung Cancer: Results from a Large Cohort Study
Christopher G. Slatore et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
A Randomized Phase II Chemoprevention Trial of 13-CIS Retinoic Acid with Or without α Tocopherol or Observation in Subjects at High Risk for Lung Cancer
Karen Kelly et al.
CANCER PREVENTION RESEARCH (2009)
Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
Fumihiro Tanaka et al.
CLINICAL CANCER RESEARCH (2009)
Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers The Selenium and Vitamin E Cancer Prevention Trial ( SELECT)
Scott M. Lippman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Low-Dose CT Screening for Lung Cancer: Trial and Error?
Kris Nackaerts et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Lung Cancer Susceptibility Model Based on Age, Family History and Genetic Variants
Robert P. Young et al.
PLOS ONE (2009)
Comparison of Proteomic and Transcriptomic Profiles in the Bronchial Airway Epithelium of Current and Never Smokers
Katrina Steiling et al.
PLOS ONE (2009)
Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium
Sriram Sridhar et al.
BMC GENOMICS (2008)
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial)
Karien A. M. van den Bergh et al.
CANCER (2008)
Prostacyclin Prevents Murine Lung Cancer Independent of the Membrane Receptor by Activation of Peroxisomal Proliferator-Activated Receptor γ
Raphael Nemenoff et al.
CANCER PREVENTION RESEARCH (2008)
A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
Jennifer Beane et al.
CANCER PREVENTION RESEARCH (2008)
An Expanded Risk Prediction Model for Lung Cancer
Margaret R. Spitz et al.
CANCER PREVENTION RESEARCH (2008)
Cost of care for elderly cancer patients in the United States
K. Robin Yabroff et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Effective doses in radiology and diagnostic nuclear medicine: A catalog
Fred A. Mettler et al.
RADIOLOGY (2008)
The LLP risk model: an individual risk prediction model for lung cancer
A. Cassidy et al.
BRITISH JOURNAL OF CANCER (2008)
Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer
Pinar B. Yildiz et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
A phase I study with exploratory pharmacodynamic endpoints of XL647, a novel spectrum selective kinase inhibitor, administered orally daily to patients (pts) with advanced solid malignancies
H. A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A risk model for prediction of lung cancer
Margaret R. Spitz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Rangaswamy Govindarajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Avrum Spira et al.
NATURE MEDICINE (2007)
Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)
Carola A. van Iersel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Lung cancer incidence in never smokers
Heather A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer
Ruiyun Li et al.
CLINICAL CANCER RESEARCH (2007)
A phase I study of myo-inositol for lung cancer chernoprevention
Stephen Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Development of novel cancer chemopreventive agents in Europe - Neglected Cinderella or rising phoenix? ESF Workshop on Cancer Chemoprevention, DKFZ, Heidelberg, September 18-20, 2005
Clarissa Gerhauser et al.
EUROPEAN JOURNAL OF CANCER (2006)
Progress in chemoprevention drug development: The promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer - A plan to move forward
Gary J. Kelloff et al.
CLINICAL CANCER RESEARCH (2006)
Validation of a model of lung cancer risk prediction among smokers
Kathleen A. Cronin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
S Zienolddiny et al.
CARCINOGENESIS (2006)
High-throughput DNA methylation profiling using universal bead arrays
M Bibikova et al.
GENOME RESEARCH (2006)
Celecoxib decreases Ki-67 proliferative index in active smokers
JT Mao et al.
CLINICAL CANCER RESEARCH (2006)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Advances in the biology of lung cancer chemoprevention
FR Hirsch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Peroxisome proliferator-activated receptor-γ (PPARγ) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC)
Y Bren-Mattison et al.
ONCOGENE (2005)
The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial
NR Anthonisen et al.
ANNALS OF INTERNAL MEDICINE (2005)
The chemopreventive agent development research program in the division of cancer prevention of the US National Cancer Institute: An overview
JA Crowell
EUROPEAN JOURNAL OF CANCER (2005)
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients
XN Tang et al.
CANCER RESEARCH (2005)
Screening for lung cancer: Current status and future directions - Thomas A. Neff lecture
JR Jett et al.
CHEST (2004)
Effects of cigarette smoke on the human airway epithelial cell transcriptome
A Spira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecularly targeted approaches to the chemoprevention of lung cancer
FR Khuri et al.
CLINICAL CANCER RESEARCH (2004)
A randomized phase IIb trial of Pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium
S Lam et al.
CLINICAL CANCER RESEARCH (2004)
Variations in lung cancer risk among smokers
PB Bach et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Interaction of radiation and smoking in lung cancer induction among workers at the Mayak Nuclear Enterprise
ZB Tokarskaya et al.
HEALTH PHYSICS (2002)
Peroxisome proliferator-activated receptor-γ is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth
M Wick et al.
MOLECULAR PHARMACOLOGY (2002)
Tobacco use and cancer: an epidemiologic perspective for geneticists
MJ Thun et al.
ONCOGENE (2002)
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer
SM Lippman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Current concepts - Screening for lung cancer
EF Patz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Lung cancer mortality in the Mayo Lung Project: Impact of extended follow-up
PM Marcus et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
N van Zandwijk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
